Effect of short term treatment of L-carnitine on tissue ACE activity in streptozotocin-induced diabetic rats

Pathophysiology

Volumn 16, Issue 1, 2009, Pages 53-56

  Sharifi, Ali M ^a,b   Zare, Behnoush ^a   Keshavarz, Morteza ^a   Ghaderpanahi, Maryam ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

ACE activity; Diabetes; L carnitine; NO; Streptozotocin

Indexed keywords

CARNITINE; DIPEPTIDYL CARBOXYPEPTIDASE; NITRIC OXIDE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HEART; KIDNEY HOMOGENATE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

EID: 67349091743     PISSN: 09284680     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pathophys.2009.02.015     Document Type: Article

References (11)

1. Itoh H., Mukoyama M., Pratt R.E., Gibbons G.H., and Dzau V.J. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J. Clin. Invest. 91 (1993) 2268-2274
2. Rizos I. Three-year survival of patients with heart failure caused by dilated cardiomyopathy and L-carnitine administration. Am. Heart J. 139 (2000) 120-123
3. Matsubara T., Koh N., Nakamura J., Hotta N., and Terada R. Effects of propionyl-L-carnitine on cardiac dysfunction in streptozotocin-diabetic rats. Eur. J. Pharmacol. 357 (1998) 185-191
4. Horiuchi M., Fujimura K., Terashima T., and Iso T. Method for determination of angiotensin-converting enzyme activity in blood and tissue by high performance liquid chromatography. J. Chromatogr. 233 (1982) 123-130
5. Sharifi A.M., Darabi R., and Akbarloo N. Study of antihypertensive mechanism of tribulus terrestris in 2K1C hypertensive rats: role of tissue ACE activity. Life. Sci. 73 (2003) 2963-2971
6. Crespo M.J., Moreta S., and Gonzales J. Cardiovascular deterioration in STZ-diabetic rats: possible role of vascular RAS. Pharmacology 68 (2003) 1-8
7. Sharifi A.M., Mousavi S.H., and Larijani B. Study of interaction between nitric oxide and ACE activity in STZ-induced diabetic rats: role of insulin. Pharmacol. Res. 50 (2004) 261-266
8. Griendling K.K., Minieri C.A., Olierenshaw J.D., and Alexander R.W. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ. Res. 74 (1994) 1141-1148
9. Da Ros R., Assaloni R., and Ceriello V. Molecular targets of diabetic vascular complications and potential new drugs. Curr. Drug Targets 6 (2005) 503-509
10. Higashi Y., Oshima T., Ono N., Hiraga H., Yoshimura M., Watanabe M., et al. Intravenous administration of L-arginine inhibits angiotensin-converting enzyme in humans. J. Clin. Endocrinol. Metab. 80 (1995) 2198-2202
11. Koeck T., and Kremser K. L-Carnitine alters nitric oxide synthase activity in fibroblasts depending on the peroxisomal status. Int. J. Biochem. Cell Biol. 35 (2003) 149-156